Alström Syndrome is a rare genetic disorder with a specific and well-understood pattern of inheritance. It is caused by mutations in a single gene known as ALMS1, which is located on the short arm of chromosome 2 (2p13). Understanding the genetics behind this condition is crucial for diagnosis, family planning, and comprehending how the disease manifests.
The ALMS1 gene provides instructions for producing a protein that is found in tissues throughout the body. Although its exact function is still being heavily researched, the ALMS1 protein is known to be involved in the function of cilia—microscopic, hair-like structures on the surface of cells. Cilia are essential for cell signaling and sensory input. Mutations in the ALMS1 gene lead to the production of a nonfunctional protein or no protein at all, disrupting ciliary function and leading to the widespread symptoms of Alström Syndrome, classifying it as a ciliopathy.
Alström Syndrome is inherited in an autosomal recessive pattern. "Autosomal" means the affected gene is located on one of the 22 non-sex chromosomes, meaning it affects males and females equally. "Recessive" means that for a child to be born with the syndrome, they must inherit two defective copies of the ALMS1 gene—one from each parent.
Parents of an individual with Alström Syndrome each carry one copy of the mutated gene and one normal copy. They are known as "carriers." Carriers typically do not show any signs or symptoms of the condition because the one normal copy of the gene is sufficient for normal cellular function.
When two carriers have a child together, there is a 25% (1 in 4) chance with each pregnancy that the child will inherit two mutated copies and develop Alström Syndrome. There is a 50% (1 in 2) chance the child will inherit one mutated copy and be a carrier like the parents, and a 25% chance the child will inherit two normal copies of the gene.
Because of this inheritance pattern, genetic testing and counseling are highly recommended for families affected by Alström Syndrome. Genetic testing can confirm a clinical diagnosis by identifying the specific mutations in the ALMS1 gene. For family members, carrier screening can determine if they hold the mutated gene, which is vital information for family planning.
Genetic counselors play a key role in helping families understand the test results, the risks of passing the condition to future children, and the available reproductive options. Anyone with a family history of Alström Syndrome or those seeking more information about their genetic risks should consult with a healthcare provider or a certified genetic counselor.